PDL-1 status was available for 194 patients with multi-hit PIK3CA CRC, of which 16.5% (32/194) of patients were PDL-1 positive compared to 11.43% (944/8,265) of the wild-type PIK3CA CRC (P = .040). The gene discussed is PIK3CA; the disease is colorectal carcinoma.